Dr. Zhi Zhang 张治
Chief Physician
Department of Thoracic Surgery, Jiangsu Cancer Hospital, Nanjing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Thoracoscopic minimally invasive treatment for lung tumors, esophageal cancer, and mediastinal tumors. Applies single-port thoracoscopy for lung and mediastinal tumors.
Dr. Zhang holds a PhD and serves as a clinical master's supervisor in thoracic surgery at Nanjing Medical University. A visiting scholar at the University of Alberta Faculty of Medicine and recipient of Jiangsu provincial talent grants. From 2022 to 2023, served as Deputy Director of Xining First Hospital.
Professional roles
- Member, Thoracic Surgery Branch, Chinese Research Hospital Association
- Member, Minimally Invasive Surgery Group, Thoracic Surgery Professional Committee, Jiangsu Branch of Chinese Medical Association
- Youth Member, Lung Cancer Professional Committee, Jiangsu Anti-Cancer Association
- Youth Member, Minimally Invasive Tumor Treatment Professional Committee
Name order: in Chinese the family name comes first (Zhang Zhi). Papers usually list the name as Zhi Zhang or Zhang Z.
Selected publications
32 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- Transl Cancer Res, 2026 (senior author): SLC12A4 promoter methylation in plasma cell-free DNA as a candidate biomarker for thyroid cancer. PubMed 42997709
- Front Immunol, 2022 (first author): Neoadjuvant sintilimab and chemotherapy in patients with resectable esophageal squamous cell carcinoma: A prospective, single-arm, phase 2 trial. PubMed 36311804
- Oncol Res, 2021 (senior author): Curcumol Inhibits Lung Adenocarcinoma Growth and Metastasis via Inactivation of PI3K/AKT and Wnt/-Catenin Pathway. PubMed 32886059
- BMC Cancer, 2021 (first author): Development of a prognostic signature for esophageal cancer based on nine immune related genes. PubMed 33541291
- Cell Physiol Biochem, 2018 (senior author): Sepia Ink Oligopeptide Induces Apoptosis of Lung Cancer Cells via Mitochondrial Pathway. PubMed 29533931
- Oncotarget, 2017 (first author): Sepia ink oligopeptide induces apoptosis and growth inhibition in human lung cancer cells. PubMed 28423568
- Zhongguo Fei Ai Za Zhi, 2006 (senior author): [Experience of carinal resection and reconstruction in the treatment of carinal tumor and bronchogenic carcinoma]. PubMed 21144272
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion